Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison ofhigh-dose conventional conditioning versusfludarabine-based reduced-intensity regimens-Reference-Cited by-同舟云学术

Allogeneic hematopoetic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison ofhigh-dose conventional conditioning versusfludarabine-based reduced-intensity regimens

Published:2002-01 Issue:1 Volume:13 Page:135-139
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Bertz H.,Illerhaus G.,Veelken H.,Finke J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/13/1/135/19479706/135.pdf

Reference13 articles.

1. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin’s lymphoma: updated results of the Utrecht experience;Verdonck;Leuk Lymph,1999

2. Prospective comparative trial of autologous versus allogeneic bone marrow transplantation in patients with non-Hodgkin’s lymphoma;Ratanatharathorn;Blood,1994

3. Allogeneic bone marrow transplantation for low-grade lymphoma;van Besien;Blood,1998

4. Allogeneic, syngeneic, and autologous marrow transplantation for Hodgkin’s disease: the 21-year Seattle experience;Anderson;J Clin Oncol,1993

5. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin’s lymphoma;de Lima;Bone Marrow Transplant,1997

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advancement in Stem Cell Therapies for Cancer Treatment;Comprehensive Hematology and Stem Cell Research;2024

2. Immunotherapy in hematologic malignancies: achievements, challenges and future prospects;Signal Transduction and Targeted Therapy;2023-08-18

3. Comparison of efficacies of haploidentical transplantation and matched sibling donor transplantation in treating T‐cell lymphoblastic lymphoma;Cancer Medicine;2023-03-29

4. Stem cells in cancer therapy: opportunities and challenges;Oncotarget;2017-09-08

5. Long-term follow-up of patients with relapsed or refractory non-Hodgkin’s lymphoma receiving allogeneic stem cell transplantation;Bone Marrow Transplantation;2016-06-13